Los Angeles Capital Management LLC Avid Bioservices, Inc. Transaction History

Los Angeles Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$11.63 - $21.55 $480,505 - $890,359	-41,316 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$16.63 - $27.73 $89,186 - $148,715	5,363 Added 14.92%	41,316 $842,000
Q4 2021 Feb 03, 2022	SELL	$20.7 - $34.18 $1,635 - $2,700	-79 Reduced 0.22%	35,953 $1.05 Million
Q3 2021 Nov 08, 2021	SELL	$19.05 - $28.32 $71,818 - $106,766	-3,770 Reduced 9.47%	36,032 $777,000
Q2 2021 Aug 05, 2021	SELL	$18.93 - $25.65 $698,990 - $947,126	-36,925 Reduced 48.13%	39,802 $1.02 Million
Q1 2021 May 05, 2021	SELL	$11.86 - $21.77 $2.25 Million - $4.12 Million	-189,360 Reduced 71.16%	76,727 $1.4 Million
Q4 2020 Feb 04, 2021	SELL	$7.25 - $11.76 $93,452 - $151,586	-12,890 Reduced 4.62%	266,087 $3.07 Million
Q3 2020 Nov 02, 2020	SELL	$6.53 - $8.6 $173,462 - $228,450	-26,564 Reduced 8.69%	278,977 $2.13 Million
Q2 2020 Aug 05, 2020	BUY	$4.11 - $6.78 $931,658 - $1.54 Million	226,681 Added 287.45%	305,541 $2.01 Million
Q1 2020 May 04, 2020	BUY	$3.15 - $7.39 $197,851 - $464,165	62,810 Added 391.34%	78,860 $403,000
Q4 2019 Feb 07, 2020	BUY	$5.01 - $8.16 $80,410 - $130,968	16,050 New	16,050 $123,000

195

70.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.